希邦医疗

最新新闻

• 评级变动
  Morgan Stanley Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $23
  \u5e02\u573a\u8d44\u8baf · 2026/2/25
• 评级变动
  Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/1/13
• 评级变动
  A Quick Look at Today's Ratings for Si-Bone(SIBN.US), With a Forecast Between $22 to $27
  \u5e02\u573a\u8d44\u8baf · 2026/2/24
• 评级变动
  BofA Securities Maintains Si-Bone(SIBN.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $24
  \u5e02\u573a\u8d44\u8baf · 2026/2/24
• Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Raises Target Price to $21
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• A Quick Look at Today's Ratings for Si-Bone(SIBN.US), With a Forecast Between $20 to $27
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  Piper Sandler Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/3/23
• CCORF Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• 评级变动
  TD Cowen Initiates Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $21
  \u5e02\u573a\u8d44\u8baf · 2026/1/27
• 评级变动
  Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• 评级变动
  Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/4/15
• 评级变动
  Needham Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27
  \u5e02\u573a\u8d44\u8baf · 2026/6/3
• 评级变动
  Morgan Stanley Initiates Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $18
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• 评级变动
  TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $21
  \u5e02\u573a\u8d44\u8baf · 2026/2/3
• TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Raises Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• 评级变动
  Jefferies Initiates Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $28
  \u5e02\u573a\u8d44\u8baf · 2026/1/9
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Sight Sciences (SGHT) and SI-Bone (SIBN)
  TipRanks · 2026/1/13

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。